The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Nanotechnology: Intelligent Design to Treat Complex Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Self-citationBiodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Applications of Carbon Nanotubes in Drug Delivery
Kaur, J., Gill, G. S., & Jeet, K. (2019) · Characterization and Biology of Nanomaterials for Drug Delivery · doi:10.1016/b978-0-12-814031-4.00005-2 · Cited by 2,019
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
A prospective randomized trial
(1995) · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · doi:10.4030/jjcs1979.20.2_191 · Cited by 1,619
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., Lee, J. H., Andrade, J. D., & De Gennes, P. G. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90043-8 · Cited by 1,523
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency
Mao, H.-Q., Roy, K., Troung-Le, V. L., Janes, K. A., Lin, K. Y., Wang, Y., August, J. T., & Leong, K. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00361-8 · Cited by 1,228
Gordon, A. N., Fleagle, J. T., Guthrie, D., Parkin, D. E., Gore, M. E., & Lacave, A. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3312 · Cited by 1,211
Scientific and Clinical Applications of Magnetic Carriers
(1997) · Springer eBooks · doi:10.1007/978-1-4757-6482-6 · Cited by 1,032
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956
Sterically stabilized liposomes
Woodle, M. C., & Lasic, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 954
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Spyr, C., & Steffen, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030595 · Cited by 916
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
Croft, S. L., & Coombs, G. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.008 · Cited by 891
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.
Wu, G. Y., & Wu, C. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61209-8 · Cited by 855
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Selective Cell Targeting with Light-Absorbing Microparticles and Nanoparticles
Pitsillides, C. M., Joe, E. K., Wei, X., Anderson, R. R., & Lin, C. P. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)75128-5 · Cited by 753
Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746
Jordan, A., Scholz, R., Maier-Hauff, K., Johannsen, M., Wust, P., Nadobny, J., Schirra, H., Schmidt, H., Deger, S., Loening, S., et al. (2001) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(00)01239-7 · Cited by 731
Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
Behr, J. P., Demeneix, B., Loeffler, J. P., & Perez-Mutul, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6982 · Cited by 719
An overview of current delivery systems in cancer gene therapy
El-Aneed, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 693
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R. J., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 692
Dvorak, H. F., Nagy, J. A., Dvorák, J., & Dvořàk, A. M. (1988) · PubMed Central · Cited by 679
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Transferrin-polycation conjugates as carriers for DNA uptake into cells.
Wagner, E., Zenke, M., Cotten, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3410 · Cited by 655
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Virus-like particles as immunogens
Noad, R., & Roy, P. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00208-7 · Cited by 581
Andresen, T. L., Jensen, S. S., & Jørgensen, K. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.12.001 · Cited by 580
May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 574
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Self-citationDesign of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Self-citationJordan, A., Scholz, R., Wust, P., Schirra, H., Schiestel, T., Schmidt, H., & Felix, R. (1999) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(98)00558-7 · Cited by 521
Polyethylenimine-mediated gene delivery: a mechanistic study
Kichler, A., Leborgne, C., Coeytaux, E., & Danos, O. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.173 · Cited by 517
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 499
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
Sonvico, F., Mornet, S., Vasseur, S., Dubernet, C., Jaillard, D., Degrouard, J., Hoebeke, J., Duguet, E., Colombo, P., & Couvreur, P. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050050z · Cited by 484
Self-citationOn the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Potentiation of Cationic Liposome-Mediated Gene Delivery by Polycations
Gao, X., & Huang, L. (1996) · Biochemistry · doi:10.1021/bi952436a · Cited by 460
Kawabata, K., Takakura, Y., & Hashida, M. (1995) · Pharmaceutical Research · doi:10.1023/a:1016248701505 · Cited by 456
Wyman, T. B., Nicol, F., Zelphati, O., Scaria, P. V., Plank, C., & Szoka, F. C. (1997) · Biochemistry · doi:10.1021/bi9618474 · Cited by 453
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
Zhang, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100120 · Cited by 432
Adjuvants designed for veterinary and human vaccines
Aucouturier, J., Dupuis, L., & Ganne, V. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00498-9 · Cited by 430
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications
Pinto-Alphandary, H., Andremont, A., & Couvreur, P. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00121-1 · Cited by 428
Self-citationToxicological Hazards of Inhaled Nanoparticles—Potential Implications for Drug Delivery
Borm, P. J. A., & Kreyling, W. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2004.081 · Cited by 419
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002) · PubMed · Cited by 417
p H-Sensitive Liposomes: Possible Clinical Implications
Yatvin, M. B., Kreutz, W., Horwitz, B. A., & Shinitzky, M. (1980) · Science · doi:10.1126/science.7434025 · Cited by 415
Nanosystems in Drug Targeting: Opportunities and Challenges
Vasir, J. K., Reddy, M. K., & Labhasetwar, V. D. (2005) · Current Nanoscience · doi:10.2174/1573413052953110 · Cited by 414
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Long-circulating iron oxides for MR imaging
Weissleder, R., Bogdanov, A., Neuwelt, E. A., & Papisov, M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00033-4 · Cited by 398
Damgé, C., Michel, C., Aprahamian, M., & Couvreur, P. (1988) · Diabetes · doi:10.2337/diab.37.2.246 · Cited by 390
Self-citationLyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5<1037::aid-cncr13>3.0.co;2-z · Cited by 385
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Bonnemain, B. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997890 · Cited by 371
Hiscock, C., & ISDALE, I. C. (1964) · PubMed · Cited by 370
Mori, A., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80699-4 · Cited by 369
Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain
Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 362
Rauschmann, M. A., Wichelhaus, T. A., Stirnal, V., Dingeldein, E., Zichner, L., Schnettler, R., & Alt, V. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.045 · Cited by 360
Polycation-based DNA complexes for tumor-targeted gene deliveryin vivo
Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K.-H., Zauner, W., & Wagner, E. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199903/04)1:2<111::aid-jgm22>3.0.co;2-y · Cited by 356
Nasal route and drug delivery systems
Türker, S., Onur, E., & Ózer, Y. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000026823.82950.ff · Cited by 354
Artemov, D., Mori, N., Okollie, B., & Bhujwalla, Z. M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10406 · Cited by 351
Carino, G. P., & Mathiowitz, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00075-1 · Cited by 347
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Gordon, A. N., Granai, C. O., Rose, P. G., Hainsworth, J., Lopez, A., Weissman, C., Rosales, R., & Sharpington, T. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3093 · Cited by 336
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
Strategies for designing and optimizing new generation vaccines
Berzofsky, J. A., Ahlers, J. D., & Belyakov, I. M. (2001) · Nature Reviews Immunology · doi:10.1038/35105075 · Cited by 334
Colloidal drug carriers: achievements and perspectives
Barratt, G. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180300002 · Cited by 333
Zhang, Y., Zhang, Y.-F., Bryant, J., Charles, A., Boado, R. J., & Pardridge, W. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0740 · Cited by 330
Nanomedicines for overcoming biological barriers
José Alonso, M. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
Schiffelers, R. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00240-2 · Cited by 310
Proniosomes: A Novel Drug Carrier Preparation
Hu, C., & Rhodes, D. G. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00122-2 · Cited by 298
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Ball, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.31 · Cited by 290
Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1777 · Cited by 286
Nanosphere based oral insulin delivery
Carino, G. P., Jacob, J. S., & Mathiowitz, E. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00247-3 · Cited by 278
Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119152 · Cited by 277
Bianco, A., Hoebeke, J., Godefroy, S., Chaloin, O., Pantarotto, D., Briand, J.-P., Muller, S., Prato, M., & Partidos, C. D. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044293y · Cited by 272
CpG motifs: the active ingredient in bacterial extracts?
Krieg, A. M. (2003) · Nature Medicine · doi:10.1038/nm0703-831 · Cited by 271
van de Wetering, P., Cherng, J.-Y., Talsma, H., & Hennink, W. E. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00059-x · Cited by 268
Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia
McClean, S., Prosser, E., Meehan, E., O'Malley, D., Clarke, N., Ramtoola, Z., & Brayden, D. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10007-0 · Cited by 260
Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges
Holmgren, J., Czerkinsky, C., Eriksson, K., & Mharandi, A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00206-8 · Cited by 260
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
Moore, A., Weissleder, R., & Bogdanov, A. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070629 · Cited by 260
Overview of the lipid formulations of amphotericin B
Dupont, B. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.31 · Cited by 260
Moghimi, S. M., Muir, I. S., Illum, L., Davis, S. S., & Kolb-Bachofen, V (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90137-e · Cited by 259
Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagie, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 257
Polyketal Nanoparticles: A New pH-Sensitive Biodegradable Drug Delivery Vehicle
Heffernan, M. J., & Murthy, N. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050176w · Cited by 257
Adler-moore, J. P., & Proffitt, R. T. (1993) · Journal of Liposome Research · doi:10.3109/08982109309150729 · Cited by 251
The virosome concept for influenza vaccines
Huckriede, A., Bungener, L., Stegmann, T., Daemen, T., Medema, J., Palache, A. M., & Wilschut, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.026 · Cited by 250
Vila, A., Gill, H., McCallion, O., & Alonso, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.026 · Cited by 249
Vinogradov, S., Batrakova, E., & Kabanov, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00080-6 · Cited by 247
Recent Advances in Vaccine Adjuvants
Singh, M., & O'Hagan, D. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016104910582 · Cited by 245
Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
Cyclosporine A delivery to the eye: A pharmaceutical challenge
Lallemand, F., Felt-Baeyens, O., Besseghir, K., Behar-Cohen, F., & Gurny, R. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00138-3 · Cited by 240
Slepushkin, V. A., Simões, S., Dazin, P., Newman, M. S., Guo, L. S., de Lima, M. C. P., & Düzgüneş, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2382 · Cited by 235
Qaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., & Lee, V. H. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022411.47059.76 · Cited by 229
Hilger, I., Andrä, W., Hergt, R., Hiergeist, R., Schubert, H., & Kaiser, W. A. (2001) · Radiology · doi:10.1148/radiology.218.2.r01fe19570 · Cited by 224
Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolism
Pouliquen, D., Le Jeune, J. J., Perdrisot, R., Ermias, A., & Jallet, P. (1991) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(91)90412-f · Cited by 222
A lipid based depot (DepoFoam® technology) for sustained release drug delivery
Mantripragada, S. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00004-8 · Cited by 221
Rat Models of Type 1 Diabetes: Genetics, Environment, and Autoimmunity
Mordes, J. P., Bortell, R., Blankenhorn, E. P., Rossini, A. A., & Greiner, D. L. (2004) · ILAR Journal · doi:10.1093/ilar.45.3.278 · Cited by 218
Barraud, L., Merle, P., Soma, E., Lefrançois, L., Guerret, S., Chevallier, M., Dubernet, C., Couvreur, P., Trépo, C., & Vitvitski, L. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.035 · Cited by 217
Self-citationMicrocrystals for dissolution rate enhancement of poorly water-soluble drugs
Rasenack, N., Hartenhauer, H., & Müller, B. W. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00005-x · Cited by 213
Köping‐Höggård, M., Mel'nikova, Y. S., Vårum, K. M., Lindman, B., & Artursson, P. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.327 · Cited by 212
Oral administration of insulin by encapsulation within liposomes
Patel, H. M., & Ryman, B. E. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80016-6 · Cited by 211
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells
Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J., & Langer, K. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010697 · Cited by 211
“Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes
Fattal, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.037 · Cited by 211
Possibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., Takizawa, T., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211
Intracellular hyperthermia for cancer using magnetite cationic liposomes
Shinkai, M., Yanase, M., Suzuki, M., Honda, H., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (1999) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(98)00586-1 · Cited by 211
Peracchia, M. T., Harnisch, S., Pinto-Alphandary, H., Gulik, A., Dedieu, J. C., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208
Self-citationShin, J. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00232-3 · Cited by 208
Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides
Mutwiri, G. K., Nichani, A. K., Babiuk, S., & Babiuk, L. A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.022 · Cited by 208
Conacher, M., Alexander, J., & Brewer, J. M. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00537-5 · Cited by 207
The role of nanobiotechnology in drug discovery
Jain, K. K. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03573-7 · Cited by 207
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
Calvo, P., Alonso, M. J., Vila-Jato, J. L., & Robinson, J. R. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb03911.x · Cited by 206
Schmidt, J., Metselaar, J. M., Wauben, M. H. M., Toyka, K. V., Storm, G., & Gold, R. (2003) · Brain · doi:10.1093/brain/awg176 · Cited by 204
Evaluation of nano- and microparticle uptake by the gastrointestinal tract
Delie, F. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00041-6 · Cited by 202
Nanoparticulate systems for the delivery of antisense oligonucleotides
Lambert, G., Fattal, E., & Couvreur, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00116-2 · Cited by 201
Self-citationLiquid filled nanoparticles as a drug delivery tool for protein therapeutics
Venkatesan, N., Yoshimitsu, J., Ιtο, Y., Shibata, N., & Takada, K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.012 · Cited by 198
Hassani, Z., Lemkine, G. F., Erbacher, P., Palmier, K., Alfama, G., Giovannangeli, C., Behr, J.-P., & Demeneix, B. A. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.659 · Cited by 198
Design of nanoparticles composed of graft copolymers for oral peptide delivery
Sakuma, S., Hayashi, M., & Akashi, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00119-8 · Cited by 194
Ward, C. M., Read, M. L., & Seymour, L. W. (2001) · Blood · doi:10.1182/blood.v97.8.2221 · Cited by 189
Nonviral Gene Delivery to the Rat Kidney with Polyethylenimine
Boletta, A., Benigni, A., Lutz, J., Remuzzi, G., Soria, M. R., & Monaco, L. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.10-1243 · Cited by 187
Virus-like particles as vaccines and vessels for the delivery of small molecules
Garcea, R. L., & Gissmann, L. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.10.002 · Cited by 187
Moreira, J. N., Ishida, T., Gaspar, R. S., & Allen, T. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1014434732752 · Cited by 183
Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles
Galindo-Rodríguez, S. A., Puel, F., Briançon, S., Allémann, E., Doelker, E., & Fessi, H. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.013 · Cited by 183
Antitumor Immunity Induction by Intracellular Hyperthermia Using Magnetite Cationic Liposomes
Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03283.x · Cited by 181
Immune effects and mechanisms of action of CpG motifs
Krieg, A. M. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00249-8 · Cited by 181
Passirani, C., Barratt, G., Devissaguet, J.-P., & Labarre, D. (1998) · Pharmaceutical Research · doi:10.1023/a:1011930127562 · Cited by 179
Poly(alkyl cyanoacrylate) Nanospheres for Oral Administration of Insulin
Damgé, C., Vranckx, H., Balschmidt, P., & Couvreur, P. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970124i · Cited by 178
Self-citationJung, T., Kamm, W., Breitenbach, A., Hungerer, K.-D., Hundt, E., & Kissel, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011063232257 · Cited by 177
Bender, A. R., von Briesen, H., Kreuter, J., Duncan, I. B. R., & Rübsamen‐Waigmann, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1467 · Cited by 177
Kerkmann, M., Costa, L. T., Richter, C., Rothenfusser, S., Battiany, J., Hornung, V., Johnson, J., Englert, S., Ketterer, T., Heckl, W., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410868200 · Cited by 177
Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages
Illum, L., Jacobsen, L. O., Müller, R. H., Mak, E., & Davis, S. S. (1987) · Biomaterials · doi:10.1016/0142-9612(87)90099-8 · Cited by 176
Measuring transferrin receptor gene expression by NMR imaging
Moore, A., Basilion, J. P., Chiocca, E. A., & Weissleder, R. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00002-0 · Cited by 174
Lee, H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00002-0 · Cited by 173
Comparative, Quantitative Study of Lymphoid and Non-Lymphoid Uptake of 60 nm Polystyrene Particles
Hillery, A., Jani, P., & Florence, A. (1994) · Journal of Drug Targeting · doi:10.3109/10611869409015904 · Cited by 169
de Verdière, A., Dubernet, C., Némati, F., Soma, E., Appel, M., Ferté, J., Bernard, S., Puisieux, F., & Couvreur, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.362 · Cited by 168
Self-citationTaddio, A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045316 · Cited by 168
Mao, S., Germershaus, O., Fischer, D., Linn, T., Schnepf, R., & Kissel, T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8175-y · Cited by 164
Lowe, P. J., & Temple, C. S. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03854.x · Cited by 164
Calvo, P., Gouritin, B., Villarroya, H., Eclancher, F., Giannavola, C., Klein, C., Andreux, J. P., & Couvreur, P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01967.x · Cited by 164
Self-citationLiposome-encapsulated aminoglycosides in pre-clinical and clinical studies
Schiffelers, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.333 · Cited by 163
Aprahamian, M., Michel, C., Humbert, W., Devissaguet, J. P., & Damge, C. (1987) · Biology of the Cell · doi:10.1111/j.1768-322x.1987.tb00571.x · Cited by 163
Investigation of lectin-modified insulin liposomes as carriers for oral administration
Zhang, N., Ping, Q. N., Huang, G. H., & Xu, W. F. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.018 · Cited by 162
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.006 · Cited by 161
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat
Kisel, M. A., Kulik, L. N., Tsybovsky, I. S., Vlasov, A. P., Vorob'yov, M. S., Kholodova, E. A., & Zabarovskaya, Z. V. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00579-8 · Cited by 161
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin
GARCIAFUENTES, M., TORRES, D., & ALONSO, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.030 · Cited by 161
Jikia, D., Chkhaidze, N., Imedashvili, E., Mgaloblishvili, I., Tsitlanadze, G., Katsarava, R. D., Morris, J. G., & Sulakvelidze, A. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01600.x · Cited by 160
Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment
Lamprecht, A., Saumet, J.-L., Roux, J., & Benoit, J.-P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.018 · Cited by 158
Andresen, T. L., Davidsen, J., Begtrup, M., Mouritsen, O. G., & Jørgensen, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031029r · Cited by 158
Pegylated Liposomal Doxorubicin: Optimizing the Dosing Schedule in Ovarian Cancer
Rose, P. G. (2005) · The Oncologist · doi:10.1634/theoncologist.10-3-205 · Cited by 158
HYPOGLYCqMIC EFFECT OF LIPOSOME-ENTRAPPED INSULIN ADMINISTERED INTRAGASTRICALLY INTO RATS
DAPERGOLAS, G., & Gregoriadis, G. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91209-5 · Cited by 154
Biomedical applications of maghemite ferrofluid
Halbreich, A., Roger, J., Pons, J.-N., Geldwerth, D., Silva, M. F. D., Roudier, M., & Bacri, J.-C. (1998) · Biochimie · doi:10.1016/s0300-9084(00)80006-1 · Cited by 154
Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection
Wong, J. P., Yang, H., Blasetti, K. L., Schnell, G., Conley, J., & Schofield, L. N. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00358-4 · Cited by 153
Novel Approaches to Vaccine Delivery
O’Hagan, D. T., & Rappuoli, R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041443.17935.33 · Cited by 153
Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles
Fattal, E., Youssef, M. T., Couvreur, P., & Andremont, A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1540 · Cited by 149
Self-citationVárallyay, P., Nesbit, G. M., Muldoon, L. L., Nixon, R. R., Delashaw, J. B., Cohen, J. I., Petrillo, A., Rink, D., & Neuwelt, E. A. (2002) · PubMed Central · Cited by 149
Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting
Florence, A. T. (2004) · Journal of drug targeting · doi:10.1080/10611860410001693706 · Cited by 147
Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., & Harashima, H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.025 · Cited by 147
Vector-mediated drug delivery to the brain
Pardridge, W. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00087-8 · Cited by 146
Nanoparticles as carriers for nasal vaccine delivery
Köping‐Höggård, M., Sánchez, A., & Alonso, M. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.185 · Cited by 143
Streptozotocin Interactions with Pancreatic β Cells and the Induction of Insulin-Dependent Diabetes
Wilson, G. L., & Leiter, E. H. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75239-1_3 · Cited by 142
Glück, U., Gebbers, J., & Glück, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7780-7786.1999 · Cited by 137
Current status and potential application of ISCOMs in veterinary medicine
Morein, B., Hu, K., & Abusugra, I. A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.004 · Cited by 136
Ewert, K. K., Ahmad, A. K., Evans, H. M., Schmidt, H., & Safinya, C. R. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020233w · Cited by 136
Progress on new vaccine strategies against chronic viral infections
Berzofsky, J. A., Ahlers, J. D., Janik, J. E., Morris, J., Oh, S., Terabe, M., & Belyakov, I. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22674 · Cited by 135
Turetschek, K., Huber, S. E., Floyd, E., Helbich, T. H., Roberts, T. P. L., Shames, D. M., Tarlo, K., Wendland, M. F., & Brasch, R. C. (2001) · Radiology · doi:10.1148/radiology.218.2.r01fe37562 · Cited by 133
Merodio, M., Irache, J. M., Valamanesh, F., & Mirshahi, M. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00284-8 · Cited by 132
Kono, K., Igawa, T., & Takagishi, T. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(96)00244-1 · Cited by 131
Albumin Nanoparticles for the Intravitreal Delivery of Anticytomegaloviral Drugs
Irache, J. M., Merodio, M., Arnedo, A., Camapanero, M., Mirshahi, M., & Espuelas, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053175335 · Cited by 131
de Kozak, Y., Andrieux, K., Villarroya, H., Klein, C., Thillaye‐Goldenberg, B., Naud, M., Garcia, E., & Couvreur, P. (2004) · European Journal of Immunology · doi:10.1002/eji.200425022 · Cited by 130
Self-citationChiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. P., & Couvreur, P. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897257 · Cited by 130
Self-citationSystemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
Gabizón, A., Peretz, T., Sulkes, A., Amselem, S., Ben‐Yosef, R., Ben-Baruch, N. E., Catane, R., Biran, S., & Barenholz, Y. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90350-7 · Cited by 130
Pan, X. Q., Wang, H., & Lee, R. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022656105022 · Cited by 124
Remsen, L. G., McCormick, C. I., Roman-Goldstein, S., Nilaver, G., Weissleder, R., Bogdanov, A. A., Jr., Hellström, K. E., Kroll, R. A., & Neuwelt, E. A. (1996) · PubMed Central · Cited by 123
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L., Gong, J., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.309 · Cited by 121
Nikitin, A. Y., Juarez-Perez, M. I., Li, S., Huang, L., & Lee, W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3916 · Cited by 120
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
Lipid based particulate formulations for the delivery of antigen
Copland, M. J., Rades, T., Davies, N. M., & Baird, M. A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01315.x · Cited by 118
EWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in Mice
Lambert, G., Bertrand, J. R., Fattal, E., Subra, F., Pinto‐Alphandary, H., Malvy, C., Auclair, C., & Couvreur, P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3963 · Cited by 118
Self-citationBiodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study.
Okon, E. E., Pouliquen, D., Okon, P., Zv, K., Tp, S., Sg, L., Kudryavtsev, B. N., & JALLET, P. (1994) · PubMed · Cited by 117
Cited by
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Metal–Organic Frameworks in Biomedicine
Horcajada, P., Gref, R., Baati, T., Allan, P. K., Maurin, G., Couvreur, P., Férey, G., Morris, R. E., & Serre, C. (2012) · Chemical Reviews · doi:10.1021/cr200256v · Cited by 4,168
Self-citationCellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Metadata
- Authors
- Couvreur, P., & Vauthier, C.
- Venue
- Pharmaceutical Research
- Published
- 2006-06-21
- Volume
- 23
- Issue
- 7
- Pages
- 1417-1450
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1992865052
- Cited by
- 948
- References
- 331
- FWCI
- 22.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.